LY3463251

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3463251, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3463251 in Healthy Participants [Phase 1]